Fasting Plasma Glucose and Glycated Hemoglobin Levels as Risk Factors for the Development of Hypertension: A Retrospective Cohort Study

References

• Wang X, Deng Y, Zhang G, et al. Spliced X-box binding protein 1 stimulates adaptive growth through activation of mTOR. Circulation. 2019;140(7):566–579. doi:10.1161/CIRCULATIONAHA.118.038924
   PubMed Web of Science ®Google Scholar
• Thacher JD, Poulsen AH, Roswall N, et al. Road traffic noise exposure and filled prescriptions for antihypertensive medication: a Danish cohort study. Environ Health Perspect. 2020;128(5):57004. doi:10.1289/EHP6273
   PubMed Web of Science ®Google Scholar
• Remchak ME, Heiston EM, Ballantyne A, et al. Insulin sensitivity and metabolic flexibility parallel plasma TCA levels in early chronotype with metabolic syndrome. J Clin Endocrinol Metab. 2022;107(8):e3487–e3496. doi:10.1210/clinem/dgac233
   PubMed Web of Science ®Google Scholar
• Murtha MJ, Eichler T, Bender K, et al. Insulin receptor signaling regulates renal collecting duct and intercalated cell antibacterial defenses. J Clin Invest. 2018;128(12):5634–5646. doi:10.1172/JCI98595
   PubMed Web of Science ®Google Scholar
• Hashemi Madani N, Ismail-Beigi F, Poustchi H, et al. Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study. BMC Cardiovasc Disord. 2020;20(1):113. doi:10.1186/s12872-020-01390-8
   PubMed Web of Science ®Google Scholar
• Di Bonito P, Sanguigno E, Forziato C, et al. Fasting plasma glucose and clustering of cardiometabolic risk factors in normoglycemic outpatient children and adolescents. Diabetes Care. 2011;34(6):1412–1414. doi:10.2337/dc10-1783
   PubMed Web of Science ®Google Scholar
• Bower JK, Appel LJ, Matsushita K, et al. Glycated hemoglobin and risk of hypertension in the atherosclerosis risk in communities study. Diabetes Care. 2012;35(5):1031–1037. doi:10.2337/dc11-2248
   PubMed Web of Science ®Google Scholar
• Kuwabara M, Chintaluru Y, Kanbay M, et al. Fasting blood glucose is predictive of hypertension in a general Japanese population. J Hypertens. 2019;37(1):167–174. doi:10.1097/HJH.0000000000001895
   PubMed Web of Science ®Google Scholar
• Schüssler-Fiorenza Rose SM, Contrepois K, Moneghetti KJ, et al. A longitudinal big data approach for precision health. Nat Med. 2019;25(5):792–804. doi:10.1038/s41591-019-0414-6
   PubMed Web of Science ®Google Scholar
• Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Suppl1):5–20. doi:10.2337/diacare.26.2007.S5
   Google Scholar
• Mahinrad S, Kurian S, Garner CR, et al. Cumulative blood pressure exposure during young adulthood and mobility and cognitive function in midlife. Circulation. 2020;141(9):712–724. doi:10.1161/CIRCULATIONAHA.119.042502
   PubMed Web of Science ®Google Scholar
• Sinha S, Haque M. Insulin resistance is cheerfully hitched with hypertension. Life. 2022;12(4). doi:10.3390/life12040564
   Google Scholar
• Kanda T, Brown JD, Orasanu G, et al. PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice. J Clin Invest. 2009;119(1):110–124. doi:10.1172/JCI36233
   PubMed Web of Science ®Google Scholar
• Anker MS, Frey MK, Goliasch G, et al. Increased resting heart rate and prognosis in treatment-naïve unselected cancer patients: results from a prospective observational study. Eur J Heart Fail. 2020;22(7):1230–1238. doi:10.1002/ejhf.1782
   PubMed Web of Science ®Google Scholar
• Lopes-Virella MF, Carter RE, Gilbert GE, et al. Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care. 2008;31(10):2006–2012. doi:10.2337/dc08-0659
   PubMed Web of Science ®Google Scholar
• Strain WD, Paldánius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018;17(1):57. doi:10.1186/s12933-018-0703-2
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1):S81–90. doi:10.2337/dc14-S081
   PubMed Web of Science ®Google Scholar
• Association American Diabetes. Updates to the standards of medical care in diabetes-2018. Diabetes Care. 2018;41(9):2045–2047. doi:10.2337/dc18-su09
   PubMedGoogle Scholar
• Lee CJ, Lim NK, Kim HC, et al. Impaired fasting glucose and impaired glucose tolerance do not predict hypertension: a community cohort study. Am J Hypertens. 2015;28(4):493–500. doi:10.1093/ajh/hpu186
   PubMed Web of Science ®Google Scholar
• Heianza Y, Arase Y, Kodama S, et al. Fasting glucose and HbA1c levels as risk factors for the development of hypertension in Japanese individuals: Toranomon hospital health management center study 16 (TOPICS 16). J Hum Hypertens. 2015;29(4):254–259. doi:10.1038/jhh.2014.77
   PubMed Web of Science ®Google Scholar
• Britton KA, Pradhan AD, Gaziano JM, et al. Hemoglobin A1c, body mass index, and the risk of hypertension in women. Am J Hypertens. 2011;24(3):328–334. doi:10.1038/ajh.2010.233
   PubMed Web of Science ®Google Scholar
• Boyko EJ, Shaw JE, Zimmet PZ, et al. A prospective study of glycemia, body size, insulin resistance and the risk of hypertension in Mauritius. J Hypertens. 2008;26(9):1742–1749. doi:10.1097/HJH.0b013e328306c965
   PubMed Web of Science ®Google Scholar
• Jarmul JA, Pignone M, Pletcher MJ. Interpreting Hemoglobin A1C in combination with conventional risk factors for prediction of cardiovascular risk. Circ Cardiovasc Qual Outcomes. 2015;8(5):501–507. doi:10.1161/CIRCOUTCOMES.115.001639
   PubMed Web of Science ®Google Scholar
• Geva M, Shlomai G, Berkovich A, et al. The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension. Cardiovasc Diabetol. 2019;18(1):53. doi:10.1186/s12933-019-0859-4
   PubMedGoogle Scholar